Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 3.29 billion Brazilian Reals [US$598.62 million]
Diagnosticos Da America SA
(4.36 billion Brazilian Reals [US$793.00 million]
of which 100%
was servi os auxiliares), and
based in BRAZIL
(2.91 billion Brazilian Reals [US$527.83 million]
of which 84%
was Diagnostic Medicine).
During the year ended December of 2019, sales at
Genomma Lab Internacional Sab De Cv were 12.71 billion Mexican Pesos (US$609.58 million).
increase of 7.8%
versus 2018, when the company's sales were 11.79 billion Mexican Pesos.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
146.3% in 2019, from
6.08 million Mexican Pesos to 14.97 million Mexican Pesos.
Not all segments of Genomma Lab Internacional Sab De Cv experienced an increase in sales in 2019:
sales of Services fell 30.8% to 48.44 million Mexican Pesos.
(However, this segment's sales were only a very small portion of the company's overall sales).